{"id":"W4296929566","doi":"10.1016/j.ejca.2022.09.002","title":"Corrigendum to ‘p53 Reactivation by PRIMA-1Met (APR-246) sensitises V600E/KBRAF melanoma to vemurafenib’[Eur J of Cancer 55 (2016) 98–110]","year":2022,"lang":"en","type":"erratum","venue":"European Journal of Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Vemurafenib; Melanoma; Medicine; Cancer research; Protein kinase B; PI3K/AKT/mTOR pathway; MAPK/ERK pathway; Metastatic melanoma; Phosphorylation; Chemistry; Signal transduction","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001897005,0.002784526,0.002850763,0.003214575,0.002858447,0.00269874,0.004093818,0.009007114,0.07866708],"category_scores_gemma":[0.01340084,0.001430059,0.002883361,0.001825402,0.001719159,0.001720587,0.002119632,0.006833605,0.05026326],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003381014,"about_ca_system_score_gemma":0.003107608,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02321176,"about_ca_topic_score_gemma":0.03823541,"domain_scores_codex":[0.9977595,0.0002267733,0.0003368138,0.0004400209,0.0009611985,0.0002756962],"domain_scores_gemma":[0.9944054,0.001283771,0.000403361,0.000419758,0.003008832,0.0004788861],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003824741,0.00001411009,0.00004351032,0.000126361,0.00001467795,0.0003126604,0.00001212287,0.00005191488,0.0002268323,0.0002251559,0.9939688,0.004965601],"study_design_scores_gemma":[0.00004214551,0.00003730803,0.001088333,0.0001170036,0.00005764395,0.0004745428,0.00002440144,0.0002101612,0.0007209323,0.0006887984,0.9965048,0.00003399372],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"other","genre_scores_codex":[0.0001391435,0.003440138,0.000553926,0.0385872,0.9516276,0.00002861034,0.0006372914,0.0003142721,0.004671741],"genre_scores_gemma":[0.00811367,0.0161558,0.004085646,0.1391108,0.357444,0.0001744143,0.004330494,0.0008977727,0.4696874],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.07866708,"threshold_uncertainty_score":0.2631676,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01528699478497751,"score_gpt":0.2587760244581139,"score_spread":0.2434890296731363,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}